Clinical Roundup Purdue’s Philip Low receives $1.3M to develop malaria drug trials using imatinib in Southeast Asia and Africa September 22, 2023Vol.49 No.35
Clinical Roundup USC study identifies mutations in 11 genes associated with aggressive prostate cancer September 22, 2023Vol.49 No.35
Clinical Roundup ColoAlert test identifies novel mRNA biomarkers in colorectal cancer, study shows September 22, 2023Vol.49 No.35
Clinical Roundup University of Arizona Cancer Center’s “Scientific Cafés” provide novel outreach September 15, 2023Vol.49 No.34
Clinical Roundup OneOncology finalizes 25 oncology and hematology pathways September 15, 2023Vol.49 No.34
Clinical Roundup Six-year outcomes from phase III CheckMate-227 show durable long-term survival with Opdivo + Yervoy in first-line treatment of mNSCLC September 15, 2023Vol.49 No.34
Clinical Roundup Intensity-modulated radiation therapy provides long-term benefits in NSCLC September 15, 2023Vol.49 No.34
Clinical Roundup Rybrevant drug combo demonstrates durable PFS in second-line EGFR-mutated NSCLC in CHRYSALIS-2 cohort September 15, 2023Vol.49 No.34
Clinical Roundup UC Irvine-led study links low-dose radiation to higher cancer risk September 15, 2023Vol.49 No.34
